A revolutionary new blood test that promises to detect cancer up to a year before tumors form has been successfully trialed at U.K. hospitals, heralding a major breakthrough in cancer detection.
Developed by Indian firm Epigeneres Biotech in 2021, the “first pan-cancer blood test” predicted the formation of tumors for at least 25 types of cancer, including breast, pancreatic, lung, and colorectal, according to the New York Post.
The trial results, which involved 1,000 patients split evenly between those affected by cancer and those unaffected, were “radically successful,” according to Ashish Tripathi, the founder and CEO of Tzar Labs and chairman of Epigeneres Biotech. “Not only can I actually detect it at this stage — I can actually tell you which cancer and where it is forming, straight from a blood test,” Tripathi revealed in an interview with medical advocate Deepak Chopra.